Matthew Splett

More than 100 graduate students and faculty attended the second annual symposium held on Oct. 14.

Friday, Nov. 3, from 10 – 11 a.m. in Auditorium 6120 Shands Building Dr. Porco’s presentation is titled “Chemical Synthesis of Complex Molecules for Translational Science”…

Wednesday, Oct. 25, from 10 – 11 a.m. in Communicore C1-017 Dr. Kou-San Ju’s presentation is titled “Genomics-Accelerated Discovery and Biosynthesis of Phosphonate Natural Products.”…

Tuesday, Oct. 17, from 2-3 p.m. in Communicore C1-011 Dr. Kodadek’s presentation is titled “In search of Catalytic Protein Inhibitors”…

Wednesday, Oct. 4, from 10 – 11 a.m. in MSB Auditorium Dr. Chevrette’s presentation is titled “Secondary metabolism across microbial ecology and evolution.”…

Wednesday, Sept. 27, from 10 – 11 a.m. in HPNP Auditorium 1404. Dr. Harris’ presentation is titled “Structure, specificity, and inhibition on Rnase P, an essential bacterial ribonucleoprotein enzyme.”…

The National Institutes of Health and the National Institute on Drug Abuse awarded a $19 million grant to advance the molecule SBS-518 into a human clinical trial.

The department of medicinal chemistry achieved several major milestones in the 2022-23 academic year.

UF researchers has received a three-year $1.5 million grant from the National Center for Complementary and Integrative Health to conduct a clinical trial on the use of kava as a tobacco cessation aid.

The department of medicinal chemistry held its annual award ceremony to recognizes the top graduate students on Aug. 9.